Jefferies Group LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$555,282
+646.0%
101,700
+906.9%
0.01%
Q1 2022$74,437
-84.5%
10,100
-87.7%
0.00%
-100.0%
Q1 2019$479,000
+44.7%
81,900
+227.6%
0.00%
+100.0%
Q4 2015$331,000
+25.9%
25,0000.0%0.00%0.0%
Q3 2015$263,00025,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders